Week in Review: Leafly layoffs, deceiving CBD labels & Detroit’s MMJ wins

By Bart Schaneman, Kristen Nichols and John Schroyer 

Leafly lays off employees amid new leadership, a study says most CBD products are improperly labeled, and Detroit voters approve pro-medical marijuana laws.

Here’s a closer look at some notable developments in the marijuana industry over the past week.


Leafly prunes workforce

Layoffs are unusual in the rapidly expanding marijuana industry.

That said, cannabis consumer website Leafly’s announcement that it laid off 15 employees is a sign the MJ industry is maturing, according to one industry insider.

“This is that grow-up moment,” said Nic Easley, CEO of Denver-based 3C Consulting.

The layoffs – about 13% of the company’s total workforce – indicate that Leafly is willing to make serious moves to trim parts of the business that are hindering the Seattle-based company, according to Easley.

“If something’s gangrene, sometimes you have to cut it off,” he noted.

Leafly now has about 100 employees.

It’s common for a business to get to 50 or 100 staffers and take a deep look under the hood to determine what’s working and what’s not, Easley said.

Instead of continuing with the status quo, the company could be preemptively saying it needs to make a change, he added.

The pruning is likely painful in the interim, but it could help Leafly achieve its long-term goals.

Easley doesn’t think the layoffs are indicative of a major problem within the industry or Leafly being concerned about competition.

“It’s more something normal that we see when companies are moving forward and start to approach that middle-market space,” Easley said.

He also believes the company’s decision to hire tech entrepreneur Chris Jeffery to succeed Drew Reynolds as CEO is par for the course.

Easley said it’s possible that Jeffery – who founded food service tech company OrderUp – is more attuned to running companies of a similar size and scope.

Leafly’s CEO choice also suggests the company is looking for a more seasoned leader than what it might find in the cannabis industry, Easley added.

“It’s not indicative of something majorly wrong with the company,” he said.

CBD labels exposed

A new study that shows most CBD labels don’t accurately reflect what’s in the product highlights the stark contrast between cannabidiol companies and their marijuana counterparts.

Marijuana skeptics seem to be real sticklers about ensuring cannabis products carry accurate THC labels that tell consumers exactly what they’re getting and, just for extra measure, contain warnings not to drive high.

So it’s especially interesting that CBD products – lauded by many marijuana foes for not containing psychoactive THC – don’t get the same scrutiny.

That’s the finding of a team of doctors who bought CBD products online and tested them to see what they contain.

The results? Less than a third of the CBD products were accurately labeled, and many bottles contained only the foggiest proximity of CBD promised on the label.

The study exposed a nagging problem in the cannabis industry:

The plants are intensely screened for THC and possible contaminants in many jurisdictions, and every Halloween the internet revs up with baseless rumors that THC is somehow being sneaked into candies and other consumer goods.

But there’s almost zero oversight of marijuana and hemp products touting high concentrations of valuable compounds.

Some in the hemp industry say the study should be a wake-up call to producers and drug regulators alike.

“This is what happens in the absence of government regulation, and consumer confidence is what’s going to suffer,” said Patrick Frankham, CEO of Pivot Pharmaceuticals in Vancouver, British Columbia, which plans to enter the CBD industry.

Big changes in Detroit

Two successful ballot measures in Detroit could eventually be huge for Motor City cannabis entrepreneurs who want to open a business.

But it probably won’t make that much of a difference for longstanding dispensaries that may have already been forced out of business by city officials.

That’s the word from attorney Matt Abel, a leading Michigan cannabis activist who has multiple clients attempting to get business licenses.

Specifically, he said, Proposal A forces the city to opt into Michigan’s medical cannabis regulatory system – which the city council had not formally done yet – and that will open the door for Detroit MMJ companies to obtain state permits.

But the bigger deal in terms of Detroit’s MMJ industry is that Proposal B rolls back a highly restrictive zoning ordinance that resulted in the closure of at least 186 dispensaries.

“They’ve already closed a good number of the ones that were in drug-free zones that may no longer be drug-free zones – places near parks and day cares and liquor stores,” Abel said. “So this removes the parks and liquor stores and day cares entirely, (and) it makes more places eligible.

“I imagine most of those that were already there had already closed. But it should open up a lot more of the city to (MMJ) development.”

The change could result in potentially hundreds more dispensaries ultimately being licensed in Detroit, Abel said.

He cautioned, however, that city officials are already discussing a possible zoning ordinance – to replace the one that was changed by the ballot measures – that would minimize how many MJ storefronts are ultimately allowed in Detroit.

So entrepreneurs hoping to open a dispensary should keep a close eye on what moves the city council may make in the near future.

Bart Schaneman can be reached at [email protected]

Kristen Nichols can be reached at [email protected]

John Schroyer can be reached at [email protected]

One comment on “Week in Review: Leafly layoffs, deceiving CBD labels & Detroit’s MMJ wins
  1. Marianne Bays on

    I’m not buying that the regulated cannabis industry, as a whole, isn’t as responsible about CBD testing and labeling as it is about THC. The problem isn’t within the regulated marijuana market … their products are not/cannot be sold on-line in any state the US and they have to meet state mandated testing criteria for safety and purity, including not just THC, but CBD as well as other cannabinoids and sometimes terpines, for the products they sell within their state in regulated retail shops/dispensaries.

    This study looked at products that were not created within the legal cannabis industry in the US, so they are either from hemp or from black market producers/sellers of cannabis products.

    Reply

Leave a Reply

Your email address will not be published. Required fields are marked *